Anderson B

School of Medicine, University of California, San Francisco.

9 papers · ORCID

ArticlePsychedelics

Psychedelic-Assisted Therapy For Death Acceptance in Terminal Illness: A Scoping Review.

Whitmore H, Anderson B, Flowers E +2

Europe PMC2026
ArticleKetamine

Effectiveness of intranasal esketamine in the treatment of patients with treatment-resistant depression: an observational study based on data collected in a Spravato treatment program at the Institute of Living, Hartford, CT.

Anderson B, Winokur A, Chan G

Europe PMC2026
ArticlePsilocybin

Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration.

Magar V, Robbins M, Fernández Lobo Blanco ÓML +10

Europe PMC2026
ArticleKetamine

An Implementation Science Assessment of Intranasal Esketamine's Limited Integration into Mainstream Psychiatric Treatment.

Anderson B, O'Grady M

Europe PMC2025
ArticlePsychedelics

Neurobiological substrates of altered states of consciousness induced by high ventilation breathwork accompanied by music.

Kartar AA, Horinouchi T, Örzsik B +11

Europe PMC2025
ArticleMDMA

A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy.

Passie T, Loizaga-Velder A, Danforth A +19

Europe PMC2026
ArticlePsychedelics

Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review

Bouchet L, Sager Z, Yrondi A +5

Europe PMC2024
ArticlePsilocybin

The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.

Johnston CB, Mangini M, Grob C +1

Europe PMC2023
ArticlePsilocybin

Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.

Leonard JB, Anderson B, Klein-Schwartz W

Europe PMC2018